City of Hope is a clinical research site located in Irvine, California, United States 92618.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
City of Hope has participated in 8 clinical trials with 6 currently active.
Therapeutic areas: Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.
Sponsors: Pierre Fabre Medicament, ORIC Pharmaceuticals, Bolt Biotherapeutics, Inc..
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
City of Hope has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
City of Hope has 8 clinical trials on record, with 6 currently active. Their work covers Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.
Yes — City of Hope holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.